Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mark Prausnitz
Emory University, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Clearside Biomedical
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Prausnitz holds equity in a privately-held company looking to develop and commercialize a technology used in this study. He serves as an Officer of the company as well.
Adjuvants for Skin Immunization: Discovery and Mechanisms
Influenza virus is one of the most common respiratory pathogens causing millions of hospitalizations worldwide every year and increased mortality in the high risk groups, young, elderly, chronically ill and pregnant women. This project aims to develop a safe, simple-to administer vaccination approach using microneedle patches encapsulating commercially available influenza vaccine and novel adjuvants to improve vaccine efficacy during a major influenza epidemic or a pandemic and increase protection of the population.
Filed on September 26, 2014.
Tell us what you know about Mark Prausnitz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Mark Prausnitz”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Husch Blackwell | |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Theranos | |
| Mark Prausnitz | Emory University | Conflict of Interest | Micron Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Clearside Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Pearl Cohen Zekek Latzer Baratz LLP | |
| Mark Prausnitz | Emory University | Conflict of Interest | Clearside Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Micron Biomedical | Value cannot be readily determined |
| Mark Prausnitz | Georgia Institute of Technology | Conflict of Interest | Moonlight Therapeutics | |
| Mark Prausnitz | Emory University | Conflict of Interest | Clearside Biomedical | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.